Please login to the form below

Not currently logged in
Email:
Password:

Biktarvy

This page shows the latest Biktarvy news and features for those working in and with pharma, biotech and healthcare.

Gilead awaits CEO and readouts to revive fortunes

Gilead awaits CEO and readouts to revive fortunes

The company’s new ‘one pill once a day’ HIV treatment Biktarvy has become the best HIV launch of all time in the US. ... Gilead saw its HIV revenues shrink in Europe due to the expected arrival of generics, but predicts this will be reversed once

Latest news

More from news
Approximately 4 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics